Screening of cervical cancer: barriers and facilitators.
作者信息
Shrivastava Saurabh R, Shrivastava Prateek S, Ramasamy Jegadeesh
机构信息
Dept. of Community Medicine, ShriSathyaSai Medical College and Research Institute, Kancheepuram, Tamil Nadu, India.
出版信息
Iran J Cancer Prev. 2013 Summer;6(3):177-8.
Abstract
摘要
相似文献
1
Screening of cervical cancer: barriers and facilitators.宫颈癌筛查：障碍与促进因素
Iran J Cancer Prev. 2013 Summer;6(3):177-8.
2
Australian women's cervical cancer screening attendance as a function of screening barriers and facilitators.澳大利亚女性宫颈癌筛查参与率与筛查障碍和促进因素的关系。
Soc Sci Med. 2019 Jan;220:396-402. doi: 10.1016/j.socscimed.2018.11.038. Epub 2018 Nov 28.
3
Knowledge, facilitators and barriers to cervical cancer screening among women in Uganda: a qualitative study.乌干达女性宫颈癌筛查的知识、促进因素和障碍：一项定性研究。
BMJ Open. 2017 Jun 11;7(6):e016282. doi: 10.1136/bmjopen-2017-016282.
4
Overcoming Barriers to Cervical Screening Among Pacific Women: A Narrative Review.克服太平洋地区女性宫颈癌筛查的障碍：一项叙述性综述
Health Equity. 2019 Feb 14;3(1):22-29. doi: 10.1089/heq.2018.0076. eCollection 2019.
5
Barriers and Facilitators to Breast and Cervical Cancer Screening Among Immigrants in the United States.美国移民的乳腺癌和宫颈癌筛查障碍及促进因素。
J Immigr Minor Health. 2019 Jun;21(3):606-658. doi: 10.1007/s10903-018-0794-6.
6
Learning From Cervical Cancer Survivors: An Examination of Barriers and Facilitators to Cervical Cancer Screening Among Women in the United States.从宫颈癌幸存者身上学习：对美国女性宫颈癌筛查障碍和促进因素的考察。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211041862. doi: 10.1177/21501327211041862.
7
What factors are most influential in increasing cervical cancer screening attendance? An online study of UK-based women.哪些因素对提高宫颈癌筛查的参与率影响最大？一项针对英国女性的在线研究。
Health Psychol Behav Med. 2020 Aug 7;8(1):314-328. doi: 10.1080/21642850.2020.1798239.
8
Young Danish HPV vaccinated women's knowledge, barriers and facilitators towards cervical cancer screening: A qualitative study.丹麦年轻接种人乳头瘤病毒疫苗女性对宫颈癌筛查的认知、障碍及促进因素：一项定性研究。
Prev Med Rep. 2021 Jul 29;24:101507. doi: 10.1016/j.pmedr.2021.101507. eCollection 2021 Dec.
9
Barriers and Facilitators to Breast and Cervical Cancer Screening in Somali Immigrant Women: An Integrative Review.索马里移民女性乳腺癌和宫颈癌筛查的障碍和促进因素：综合评价。
Oncol Nurs Forum. 2020 Mar 1;47(2):177-186. doi: 10.1188/20.ONF.177-186.
10
Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.加拿大安大略省农村地区女性宫颈癌筛查的障碍与促进因素：自我采集人乳头瘤病毒检测的作用
J Rural Health. 2016 Spring;32(2):136-45. doi: 10.1111/jrh.12136. Epub 2015 Aug 12.
引用本文的文献
1
Exploring the barriers to Pap smear test in Iranian women: a qualitative study.探讨伊朗女性巴氏涂片检查障碍：一项定性研究。
BMC Womens Health. 2021 Aug 6;21(1):287. doi: 10.1186/s12905-021-01428-9.
2
Facilitating Factors and Barriers of Women's Cancer Screening in Iran: A Systematic Review.伊朗女性癌症筛查的促进因素与障碍：一项系统综述
Int J Prev Med. 2020 Dec 11;11:199. doi: 10.4103/ijpvm.IJPVM_509_18. eCollection 2020.
本文引用的文献
1
Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis.自我采集 HPV 检测提高宫颈癌筛查参与度：系统评价和荟萃分析。
Can J Public Health. 2013 Feb 11;104(2):e159-66. doi: 10.1007/BF03405681.
2
Telemedical cervical cancer screening to bridge medicaid service care gap for rural women.远程医疗宫颈癌筛查，弥合农村妇女医疗补助服务差距。
Telemed J E Health. 2013 May;19(5):403-8. doi: 10.1089/tmj.2012.0148.
3
Changes in cervical cancer screening behavior for women attending Pap Test Week clinics.参加巴氏涂片检查周诊所的女性宫颈癌筛查行为的变化。
Int J Womens Health. 2013 Apr 8;5:141-8. doi: 10.2147/IJWH.S41214. Print 2013.
4
Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria.尼日利亚东南部埃努古女性医护人员对人乳头瘤病毒疫苗和宫颈癌筛查的接受度
Niger J Clin Pract. 2013 Apr-Jun;16(2):249-52. doi: 10.4103/1119-3077.110141.
5
Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination.社会人口因素导致的性行为和宫颈癌筛查不平等：对人乳头瘤病毒疫苗接种成功的影响。
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):641-52. doi: 10.1158/1055-9965.EPI-12-1173.
6
Cervical cancer screening: what's new and what's coming?宫颈癌筛查：有哪些新进展和新动向？
Cleve Clin J Med. 2013 Mar;80(3):153-60. doi: 10.3949/ccjm.80a.12092.
7
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis.1980 年至 2010 年 187 个国家的乳腺癌和宫颈癌：系统分析。
Lancet. 2011 Oct 22;378(9801):1461-84. doi: 10.1016/S0140-6736(11)61351-2. Epub 2011 Sep 14.
8
Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among U.S. health care providers.美国卫生保健提供者中的低危型人乳头瘤病毒检测和其他不推荐的人乳头瘤病毒检测做法。
Obstet Gynecol. 2011 Jul;118(1):4-13. doi: 10.1097/AOG.0b013e3182210034.
9
Human papillomavirus: clinical manifestations and prevention.人乳头瘤病毒：临床表现与预防。
Am Fam Physician. 2010 Nov 15;82(10):1209-13.
10
Overcoming the barriers to HPV vaccination in high-risk populations in the US.克服美国高危人群 HPV 疫苗接种障碍。
Gynecol Oncol. 2010 Jun;117(3):486-90. doi: 10.1016/j.ygyno.2010.02.011. Epub 2010 Mar 29.
Zotero 插件